Fitbit Takes Another Direct Shot at Apple Watch

Fitbit's (NYSE: FIT) most popular smartwatch to date has been the Versa, thanks in large part to a relatively affordable price tag. The Ionic, which flopped a few years back, had been more expensive in comparison. The wearable gadget maker has just unveiled its lineup heading into the holiday shopping season, which includes a new smartwatch that will try once again attempt to challenge Apple (NASDAQ: AAPL) directly.

Here's what investors need to know about the Fitbit Sense.

Fitbit's new Sense smartwatch

Fitbit Sense. Image source: Fitbit.

Dollars and Sense

The Sense may borrow from the Versa's overall aesthetic, but Fitbit is packing in more features to justify the higher $330 price tag. That includes an electrodermal activity (EDA) sensor that the company says can help users manage stress levels and also has the ability to take an electrocardiogram (ECG) once the FDA clears the device for that functionality. Apple Watch added ECGs, which can help detect signs of atrial fibrillation (AFib), in 2018.

There will also be an on-wrist skin temperature sensor, as well as the same SpO2 sensor that Fitbit has been including on its products in recent years for blood oxygen monitoring. Apple Watch does not currently monitor stress, temperature, or blood oxygen levels. Placing your palm on the smartwatch face will activate the EDA sensor and look for minor electrical changes in the sweat on a user's skin. The Sense will then combine about a dozen biometric inputs, including heart rate, sleep, and activity data in order to calculate a Stress Management Score.

Fitbit is also including a six-month trial of Fitbit Premium, the new subscription service that now has roughly 500,000 paid subscribers. Sense will undercut the $399 Apple Watch Series 5, but cost more than the $199 Apple Watch Series 3.

Fitbit's Versa smartwatch

Versa 3 looks similar to Sense. Image source: Fitbit.

Refreshing the rest

The wearable tech company is also refreshing the Versa with a third-generation model that has some fairly minor updates. The Versa 3 doesn't have as many sensors as the Sense, but Fitbit added a built-in speaker to make it easier to use virtual assistants and built-in GPS.

The Versa 2 had incorporated Amazon's Alexa, and the new model is adding Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) Google Assistant to the mix, which is unsurprising considering the search giant's pending acquisition of Fitbit. The Versa 3 is getting a slight price bump, now starting at $230 compared to its predecessor's $200 entry-level price point.

At the low end of the pricing spectrum, Fitbit is updating the Inspire 2, a basic tracker that will cost just $100. Inspire 2 is bundled with a one-year trial to Fitbit Premium (worth $80), a generous inclusion that offers a compelling value proposition.

Looking ahead

The updated lineup will need to carry Fitbit through the holidays at a time when Fitbit's unit volumes have been slipping and Google works to secure regulatory approval amid a European Commission antitrust investigation that is scrutinizing the proposed acquisition. The concern is that Google will leverage sensitive health data for ad targeting, and Fitbit's progress in developing new wellness metrics will likely only give more ammo to critics.

Meanwhile, Apple -- which grabbed over half of global smartwatch revenue in the first half of the year -- will soon host its annual fall product event and show off Apple Watch Series 6, which is expected to add blood oxygen monitoring and features related to mental health.

10 stocks we like better than Fitbit
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Fitbit wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks


*Stock Advisor returns as of August 1, 2020


John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Evan Niu, CFA owns shares of Amazon and Apple. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Amazon, Apple, and Fitbit and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.